CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

Right arrow Help viewing high resolution images
Right arrow Return to article


Fig. 5. Tumorigenic 10W2T cells lack Gab1 expression and fail to recruit SHP-2 to activated EGFR. 10W2T cells were treated with or without 100 ng/ml EGF at 37°C for 1 min. Cells were lysed, and the immunoprecipitation (IP) was performed with specific antibodies for SHP-2 (Lanes 3 and 4), Gab1 (Lanes 5 and 6), EGFR (Lanes 7 and 8), or with NRS as controls (Lanes 1 and 2). Samples were analyzed by SDS-PAGE and immunoblotting with anti-p-Tyr antibody, followed by ECL. The data shown are representative of three independent experiments.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation